$MNOV
MEDICINOVA INC

2019 Q1 Form 10-K Financial Statement

#000156459019002835 Filed on February 13, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q4 2018 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.350M $280.0K $4.660M
YoY Change 11.67% -87.56% 84.92%
% of Gross Profit
Research & Development $1.500M $210.0K $2.300M
YoY Change -6.25% -81.9% 91.67%
% of Gross Profit
Depreciation & Amortization $6.134K $10.00K $10.00K
YoY Change -8.3% 0.0% 0.0%
% of Gross Profit
Operating Expenses $1.500M $492.0K $7.028M
YoY Change -67.86% -85.55% 85.33%
Operating Profit -$4.979M -$7.028M
YoY Change 6.7% 85.35%
Interest Expense $300.0K $290.0K $270.0K
YoY Change 130.77% 383.33% 575.0%
% of Operating Profit
Other Income/Expense, Net -$22.08K $0.00 -$20.68K
YoY Change 182.48% -100.0% 524.99%
Pretax Income -$4.700M -$210.0K -$6.780M
YoY Change 3.52% -93.75% 80.65%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.697M -$208.0K -$6.780M
YoY Change 3.39% -87.02% 80.56%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$110.7K -$5.012K -$161.9K
COMMON SHARES
Basic Shares Outstanding 42.17M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $63.20M $62.30M $62.40M
YoY Change 0.48% 122.5% 154.69%
Cash & Equivalents $63.21M $62.31M $62.44M
Short-Term Investments
Other Short-Term Assets $600.0K $400.0K $400.0K
YoY Change 0.0% 33.33% -20.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $63.80M $62.76M $62.80M
YoY Change 0.31% 121.54% 151.2%
LONG-TERM ASSETS
Property, Plant & Equipment $300.0K $53.13K $100.0K
YoY Change 200.0% -15.51% 0.0%
Goodwill $9.600M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change -100.0% -100.0%
Other Assets $0.00 $10.96K $0.00
YoY Change 0.0%
Total Long-Term Assets $14.70M $14.46M $14.50M
YoY Change -2.65% -4.15% -3.97%
TOTAL ASSETS
Total Short-Term Assets $63.80M $62.76M $62.80M
Total Long-Term Assets $14.70M $14.46M $14.50M
Total Assets $78.50M $77.22M $77.30M
YoY Change -0.25% 77.85% 92.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $300.0K $616.8K $600.0K
YoY Change -25.0% -59.43% 100.0%
Accrued Expenses $1.100M $1.575M $1.200M
YoY Change 37.5% 15.76% -14.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.400M $2.192M $1.800M
YoY Change 16.67% -23.92% 5.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $240.4K $27.21K $1.700M
YoY Change -85.86% -98.4% 0.0%
Total Long-Term Liabilities $240.4K $27.21K $1.700M
YoY Change -85.86% -98.4% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.400M $2.192M $1.800M
Total Long-Term Liabilities $240.4K $27.21K $1.700M
Total Liabilities $3.500M $4.115M $3.700M
YoY Change 12.9% -13.86% -31.48%
SHAREHOLDERS EQUITY
Retained Earnings -$356.1M -$355.9M
YoY Change
Common Stock $429.3M $429.6M
YoY Change 12.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $75.04M $73.11M $73.55M
YoY Change
Total Liabilities & Shareholders Equity $78.50M $77.22M $77.28M
YoY Change -0.25% 77.93% 92.71%

Cashflow Statement

Concept 2019 Q1 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$4.697M -$208.0K -$6.780M
YoY Change 3.39% -87.02% 80.56%
Depreciation, Depletion And Amortization $6.134K $10.00K $10.00K
YoY Change -8.3% 0.0% 0.0%
Cash From Operating Activities -$3.029M -$1.640M -$1.740M
YoY Change -25.78% 57.69% -9.38%
INVESTING ACTIVITIES
Capital Expenditures $1.953K $0.00 $0.00
YoY Change -77.25%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$1.953K $0.00 $0.00
YoY Change -77.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.929M 1.520M 10.00K
YoY Change -89.93% -66.3% -99.72%
NET CHANGE
Cash From Operating Activities -3.029M -1.640M -1.740M
Cash From Investing Activities -1.953K 0.000 0.000
Cash From Financing Activities 3.929M 1.520M 10.00K
Net Change In Cash 896.2K -120.0K -1.730M
YoY Change -97.44% -103.46% -205.49%
FREE CASH FLOW
Cash From Operating Activities -$3.029M -$1.640M -$1.740M
Capital Expenditures $1.953K $0.00 $0.00
Free Cash Flow -$3.031M -$1.640M -$1.740M
YoY Change -25.89% 57.69% -9.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62313418
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27991743
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
444942
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
336580
CY2018Q4 us-gaap Assets Current
AssetsCurrent
62758360
CY2017Q4 us-gaap Assets Current
AssetsCurrent
28328323
CY2018Q4 us-gaap Goodwill
Goodwill
9600240
CY2017Q4 us-gaap Goodwill
Goodwill
9600240
CY2018Q4 mnov In Process Research And Development
InProcessResearchAndDevelopment
4800000
CY2017Q4 mnov In Process Research And Development
InProcessResearchAndDevelopment
4800000
CY2017Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
616657
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
62886
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10958
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10958
CY2018Q4 us-gaap Assets
Assets
77222692
CY2018Q2 dei Entity Public Float
EntityPublicFloat
314684033
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42171810
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9961012
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8803347
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7362662
CY2017 us-gaap Operating Expenses
OperatingExpenses
13027093
CY2016 us-gaap Operating Expenses
OperatingExpenses
10881834
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-22894
CY2018 us-gaap Interest Income Other
InterestIncomeOther
939909
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Assets
Assets
43419064
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
616753
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1520225
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1575161
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1360744
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2191914
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2880969
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
27211
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
201792
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1694163
CY2017Q4 us-gaap Liabilities
Liabilities
4776924
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
429289968
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
380156510
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42081306
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36452893
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42081306
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36452893
CY2018 mnov Research Development And Patents Expense
ResearchDevelopmentAndPatentsExpense
5625814
CY2017 mnov Research Development And Patents Expense
ResearchDevelopmentAndPatentsExpense
4223746
CY2017 us-gaap Interest Income Other
InterestIncomeOther
145508
CY2016 us-gaap Interest Income Other
InterestIncomeOther
66647
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25601
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-47038
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
829526
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6923934
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6546213
CY2018 us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
636524
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10200
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
84483
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
626324
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-84483
CY2018 mnov Proceeds From Issuance Of Common Stock Exercise Of Common Stock Options And Warrants Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockExerciseOfCommonStockOptionsAndWarrantsNetOfIssuanceCosts
42757772
CY2017 mnov Proceeds From Issuance Of Common Stock Exercise Of Common Stock Options And Warrants Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockExerciseOfCommonStockOptionsAndWarrantsNetOfIssuanceCosts
10719707
CY2016 mnov Proceeds From Issuance Of Common Stock Exercise Of Common Stock Options And Warrants Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockExerciseOfCommonStockOptionsAndWarrantsNetOfIssuanceCosts
8577907
CY2018 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
51009
CY2017 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
77319
CY2016 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
87729
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
42808781
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10797026
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8665636
CY2018 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
691
CY2016 mnov Warrant Exercises
WarrantExercises
7588852
CY2017 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
77319
CY2017 mnov Stock Issued During Period Value Under At The Market Equity Distribution And Sales Agreements
StockIssuedDuringPeriodValueUnderAtTheMarketEquityDistributionAndSalesAgreements
9891315
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
426013
CY2017 mnov Warrant Exercises
WarrantExercises
402378
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6330305
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
51009
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38472971
CY2018 mnov Stock Issued During Period Value Under At The Market Equity Distribution And Sales Agreements
StockIssuedDuringPeriodValueUnderAtTheMarketEquityDistributionAndSalesAgreements
1515105
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
407196
CY2018 mnov Warrant Exercises
WarrantExercises
2362500
CY2018 us-gaap Profit Loss
ProfitLoss
-14675087
CY2017 us-gaap Profit Loss
ProfitLoss
-11163136
CY2016 us-gaap Profit Loss
ProfitLoss
-10865979
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
6330305
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
4474945
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
3972533
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25881
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28098
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14127
CY2016 mnov Tax Expense Benefit From Fluctuations In Other Comprehensive Income
TaxExpenseBenefitFromFluctuationsInOtherComprehensiveIncome
-1901
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
19867
CY2016 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-32139
CY2018 mnov Increase Decrease In Receivables Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInReceivablesPrepaidDeferredExpenseAndOtherAssets
111682
CY2017 mnov Increase Decrease In Receivables Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInReceivablesPrepaidDeferredExpenseAndOtherAssets
-242064
CY2016 mnov Increase Decrease In Receivables Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInReceivablesPrepaidDeferredExpenseAndOtherAssets
-175495
CY2018 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-663671
CY2017 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
1246630
CY2016 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
127373
CY2017 mnov Increase Decrease In Deferred Tax Liability Deferred Revenue And Other Long Term Liabilities
IncreaseDecreaseInDeferredTaxLiabilityDeferredRevenueAndOtherLongTermLiabilities
-1754208
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9114121
CY2017 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
614
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
6348
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
34321675
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3873706
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2041288
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24118037
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22076749
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
6005
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
9203
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
6035
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.85%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;). The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentrations and Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.85%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains cash balances at various financial institutions and such balances commonly exceed the $250,000 amount insured by the Federal Deposit Insurance Corporation. The Company also maintains money market funds at various financial institutions which are not federally insured although are invested primarily in U.S. government securities. The Company has not experienced any losses in such accounts and management believes that the Company does not have significant credit risk with respect to such cash and cash equivalents.</p>
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
182847
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
144234
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
149951
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1532
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1404
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
479968
CY2018Q4 mnov Working Capital Net
WorkingCapitalNet
60600000
CY2018Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2016 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2018 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2017 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2016 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5300000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3900000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3100000
CY2018 mnov Patents Expense
PatentsExpense
300000
CY2017 mnov Patents Expense
PatentsExpense
300000
CY2016 mnov Patents Expense
PatentsExpense
400000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6609647
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6264038
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5499084
CY2018Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
16121
CY2017Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
15742
CY2018Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
235095
CY2017Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
233441
CY2018Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
285446
CY2017Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
285418
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
536662
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
534601
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
483528
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
471715
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1137869
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
952470
CY2018Q4 mnov Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
226597
CY2017Q4 mnov Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
122665
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
18763
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
144105
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
191932
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
141504
CY2018Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P4Y1M
CY2018 mnov Lease Expiration Month And Year
LeaseExpirationMonthAndYear
2021-12
CY2016 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
256314
CY2017Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
253
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4133969
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1158000
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
172585
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
687367
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4432017
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1195000
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
105579
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
7400
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5514038
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1222000
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
125391
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6609647
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5408814
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.69
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.00
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.81
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
11.27
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.47
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.10
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.04
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.76
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.03
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.11
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.25
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.52
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.61
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.07
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1261837
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1283004
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1200833
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.73
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.57
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
3.78
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
4.04
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
407196
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
426013
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
829526
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
788423
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
198164
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
414572
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M25D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M25D
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
23600000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13600000
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
22200000
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
12900000
CY2018 mnov Stock Issuance Limit Under Employee Stock Purchase Plan Description
StockIssuanceLimitUnderEmployeeStockPurchasePlanDescription
shares reserved automatically increase each year by a number equal to the lesser of: (i) 15,000 shares; (ii) 1% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year; or (iii) such lesser amount as determined by the Board
CY2018 mnov Employee Stock Purchase Plan Offering Period
EmployeeStockPurchasePlanOfferingPeriod
P6M
CY2018 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
7094
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.78
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.64
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
300000
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.052
CY2018 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P10D
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-14689617
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-12940362
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-10892276
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
19807
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
33176
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
30050
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14669810
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-12907186
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10862226
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-1489
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-412
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
5276
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
10158
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
5655
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
5276
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
10158
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3754
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1329888
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-424320
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1754208
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
62025000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
59480000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
286000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
429000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
8160000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
75247000
CY2018Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
1343000
CY2017Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
1343000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1343000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1343000
CY2018Q4 mnov Deferred Tax Assets Liabilities Before Valuation Allowance
DeferredTaxAssetsLiabilitiesBeforeValuationAllowance
73904000
CY2017Q4 mnov Deferred Tax Assets Liabilities Before Valuation Allowance
DeferredTaxAssetsLiabilitiesBeforeValuationAllowance
69883000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
74106000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
70085000
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
202000
CY2017Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
202000
CY2018 mnov Increase In Ownership Percentage
IncreaseInOwnershipPercentage
0.50
CY2018 mnov Cumulative Stock Ownership Change Period
CumulativeStockOwnershipChangePeriod
P3Y
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.064
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.035
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.015
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.011
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.009
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.272
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
2.474
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.084
CY2018 mnov Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.001
CY2017 mnov Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.003
CY2016 mnov Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.001
CY2017 mnov Effective Income Tax Rate Reconciliation Expiration Of Attributes
EffectiveIncomeTaxRateReconciliationExpirationOfAttributes
-0.187
CY2016 mnov Effective Income Tax Rate Reconciliation Expiration Of Attributes
EffectiveIncomeTaxRateReconciliationExpirationOfAttributes
-0.172
CY2017 mnov Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017
-2.537
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.017
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.029
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.136
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.004
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.135
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2017Q4 mnov Tax Cuts And Jobs Act Of2017 Change In Tax Rate Deferred Tax Asset Change In Amount
TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetChangeInAmount
32700000
CY2017Q4 mnov Tax Cuts And Jobs Act Of2017 Change In Tax Rate Deferred Tax Asset Valuation Allowance Change In Amount
TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetValuationAllowanceChangeInAmount
33400000
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
76903
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
65995
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
66289
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
4667000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
3400000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
7028000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
492000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-4543000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-3144000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-6780000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-208000
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4543000
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3144000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6780000
CY2018Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-208000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
3792000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
3406000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-3755000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-1602000
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3755000
CY2017Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1602000
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02

Files In Submission

Name View Source Status
0001564590-19-002835-index-headers.html Edgar Link pending
0001564590-19-002835-index.html Edgar Link pending
0001564590-19-002835.txt Edgar Link pending
0001564590-19-002835-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gvwrkrqrw3o1000001.jpg Edgar Link pending
mnov-10k_20181231.htm Edgar Link pending
mnov-20181231.xml Edgar Link completed
mnov-20181231.xsd Edgar Link pending
mnov-20181231_cal.xml Edgar Link unprocessable
mnov-20181231_def.xml Edgar Link unprocessable
mnov-20181231_lab.xml Edgar Link unprocessable
mnov-20181231_pre.xml Edgar Link unprocessable
mnov-ex231_6.htm Edgar Link pending
mnov-ex311_8.htm Edgar Link pending
mnov-ex312_10.htm Edgar Link pending
mnov-ex321_9.htm Edgar Link pending
mnov-ex322_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending